Search
01/04/2026
Rheumatologists' perceptions of biosimilar use in Spain: the CUSTODIAN study
Corominas, H, Guigini, MA, Ameruso, YS, Reina, D. Rheumatologists' perceptions of biosimilar use in Spain: the CUSTODIAN study. CURRENT MEDICAL RESEARCH AND OPINION. 2026; 42(2)DOI:10.1080/03007995.2026.2656544. PMID:42030169. IF:2.200(Q2/3D).
01/04/2026
Early care limitation after ICH in a population-based study: what drives clinicians' decisions?
Lambea-Gil, A, Camps-Renom, P, Martí-Fàbregas, J, Guasch-Jiménez, M, Ezcurra-Díaz, G, Fernández-Vidal, JM, Prats-Sanchez, L, Martínez-Domeño, A, de la Ossa, NP, Ramos-Pachón, A. Early care limitation after ICH in a population-based study: what drives clinicians' decisions?. European Stroke Journal. 2026; 11(4)DOI:10.1093/esj/aakag028. PMID:41947561. IF:4.500(Q1/2D).
01/04/2026
Biomarkers for advancing diagnosis and prognosis in stroke
Tiedt, S, Bustamante, A, Cameron, A, Camps-Renom, P, Grosse, GM, Ospel, J, Volbers, B, Audebert, HJ, Aulin, J, Cheng, BS, Cordonnier, C, Coutinho, JM, Fonseca, AC, Hill, MD, Jensen, M, Jern, C, Kamtchum-Tatuene, J, Katan, M, Kelly, PJ, Kopczak, A, Lemmens, R, Lindgren, AG, Loan, JJM, Nolte, CH, Puy, L, Saba, L, Salman, RA, Sandset, EC, Selim, MH, Seners, P, Sprigg, N, Tsai, HH, Doyle, KM, Montaner, J, Schreuder, FHBM, Sposato, L, Samarasekera, N, Mccabe, JJ. Biomarkers for advancing diagnosis and prognosis in stroke. LANCET NEUROLOGY. 2026; 25(4)DOI:10.1016/S1474-4422(25)00480-6. PMID:41864237. IF:45.500(Q1/1D).
01/04/2026
Two exploratory studies to investigate the role of self and emotional dysregulation in borderline personality disorder
Soler, J, Borao, L, Schmidt, C, Martinez-Rubio, D, Cebolla, A, Montero-Marin, J, García-Campayo, J, Gascon-Santos, S, Pascual, JC. Two exploratory studies to investigate the role of self and emotional dysregulation in borderline personality disorder. EUROPEAN JOURNAL OF PSYCHIATRY. 2026; 40(2)DOI:10.1016/j.ejpsy.2026.100347. PMID:. IF:1.500(Q3/7D).
01/04/2026
Compulsive sexual behavior in cocaine use disorder: Treatment outcomes and clinical challenges
Palazón-Llecha, A, Trujols, J, Madre, M, Duran-Sindreu, S, Batlle, F, Mallorquí-Bagué, N. Compulsive sexual behavior in cocaine use disorder: Treatment outcomes and clinical challenges. ACTA PSYCHOLOGICA. 2026; 264DOI:10.1016/j.actpsy.2026.106574. PMID:41812393. IF:2.700(Q2/3D).
01/04/2026
Final clinical data of a phase 1 dose-escalation study of WVT078, a BCMA×CD3 bispecific antibody, alone and in combination with ?-secretase inhibitor WHG626 in patients with relapsed and/or refractory multiple myeloma
Schjesvold, F, Spencer, A, Cohen, YC, Ocio, EM, Lopez-Pardo, J, Cafro, AM, Callander, NS, Kaufman, JL, Mohan, M, Wermke, M, Doki, N, Kan, RBC, Milanez-Almeida, P, Stein, A, Trabucco, G, Ye, S, Kulec, K, Sechaud, R, Banerjee, S, Zhong, HQ, Lai, CT, Rauch, PJ, Raab, MS. Final clinical data of a phase 1 dose-escalation study of WVT078, a BCMA×CD3 bispecific antibody, alone and in combination with ?-secretase inhibitor WHG626 in patients with relapsed and/or refractory multiple myeloma. CANCER. 2026; 132(7)DOI:10.1002/cncr.70341. PMID:41880322. IF:5.100(Q1/3D).
01/04/2026
Evolving Patterns of EBV-Associated PTLD After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter GETH-TC Study
García-Cadenas, I, Guerreiro, M, Yañez, L, Chorao, P, Martin, F, Suárez-Lledó, M, Pérez, A, Tomás, LG, López, J, Marsal, J, Romero, N, Huguet, M, Zabalza, A, González-Vicent, M, Vázquez, L, Silva, P, Gil, D, Micó-Cerdà, M, Sánchez, P, Filaferro, S, Balsalobre, P, Jiménez-Ubieto, A, Martino, R, Piñana, JL. Evolving Patterns of EBV-Associated PTLD After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter GETH-TC Study. EUROPEAN JOURNAL OF HAEMATOLOGY. 2026; 116(4)DOI:10.1111/ejh.70109. PMID:41502050. IF:2.300(Q2/5D).
01/04/2026
Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study
Mikulska, M, Tridello, G, Ljungman, P, Styczynski, J, Averbuch, D, Cesaro, S, Knelange, N, Wendel, L, Piñana, JL, Popova, M, Kröger, N, Sengeloev, H, Besley, C, Labussiere-Wallet, H, Yegin, ZA, Greco, R, Baron, F, Yonal-Hindilerden, I, Xhaard, A, Metafuni, E, Verbeek, M, Byrne, J, Toprak, SK, Grassi, A, Vallisa, D, Clay, J, Bufarull, RM, Van Gorkom, G, Sevindik, OG, Wilson, K, de la Camara, R. Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study. BONE MARROW TRANSPLANTATION. 2026; 61(4)DOI:10.1038/s41409-026-02819-y. PMID:41795056. IF:5.200(Q1/1D).
01/04/2026
Assessing the Value Contribution of Vyvgart® (Efgartigimod Alfa) in the Treatment of Generalized Myasthenia Gravis with Acetylcholine Receptor Antibody in Spain Through Multi-criteria Decision Analysis
Cortés-Vicente, E, Guerrero, A, Díaz, C, Martínez, E, Toja-Camba, FJ, Abad, MR, Serra, JM, Trillo, JL, Machín, CM, Gil, A. Assessing the Value Contribution of Vyvgart® (Efgartigimod Alfa) in the Treatment of Generalized Myasthenia Gravis with Acetylcholine Receptor Antibody in Spain Through Multi-criteria Decision Analysis. ADVANCES IN THERAPY. 2026; 43(4)DOI:10.1007/s12325-026-03490-x. PMID:41591648. IF:4.000(Q1/3D).
01/04/2026
Clinical Heterogeneity and Candidate Biomarkers in POLG-Related Mitochondrial Disease
Bermejo-Guerrero, L, Restrepo-Vera, JL, Martin-Jimenez, P, Navarro-Riquelme, M, Garrido-Moraga, R, Ochoa, LE, González-Quintana, A, Hernandez-Lain, A, Castillo-Villalba, J, Morís, G, Muelas, N, García-Arumí, E, González, V, Martínez-Sáez, E, Vesperinas, A, Llansó, L, Juntas-Morales, R, Paradas, C, Kapetanovic, S, Blázquez, A, Martí, R, Arenas, J, Martín, MA, Domínguez-González, C. Clinical Heterogeneity and Candidate Biomarkers in POLG-Related Mitochondrial Disease. Neurology-Genetics. 2026; 12(2)DOI:10.1212/NXG.0000000000200365. PMID:41822038. IF:3.700(Q1/3D).
01/04/2026
Myasthenia gravis in Spain: A survey of specialized neurologists to uncover unmet needs
Cortés-Vicente, E, Casasnovas, C, Juntas, R, Sevilla, T, Pardo, J, de Rivera, FR, Sola, AG. Myasthenia gravis in Spain: A survey of specialized neurologists to uncover unmet needs. NEUROLOGIA. 2026; 41(3)DOI:10.1016/j.nrl.2025.501912. PMID:. IF:3.100(Q2/4D).
01/04/2026
Fulzerasib plus cetuximab in first-line KRASG12C-mutated nonsmall-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial
Gregorc, V, Majem, M, Lo Russo, G, Maio, M, Salvagni, S, Gutiérrez-Calderon, V, Gonzalez-Cao, M, Contreras, SS, Koumarianou, A, Bearz, A, Bernabé-Caro, R, Viteri, S, de Sanmamed, MF, Zagouri, F, Bueno, TM, Lazzari, C, Martínez-Recio, S, Giménez-Capitán, A, Zhang, Y, Shan, Y, Zhu, HQ, Zhao, CQ, Shen, HG, Wang, Y, Rosell, R. Fulzerasib plus cetuximab in first-line KRASG12C-mutated nonsmall-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial. LANCET ONCOLOGY. 2026; 27(4)DOI:10.1016/S1470-2045(25)00764-8. PMID:41926959. IF:35.900(Q1/1D).
01/04/2026
Identification of prognostic variables in patients with recurrent head and neck squamous cell carcinoma treated with salvage surgery: Implications for treatment with immunotherapy
Holgado, A, Llansana, A, Vázquez, C, Gallego, O, Aguado, M, Valero, C, León, X. Identification of prognostic variables in patients with recurrent head and neck squamous cell carcinoma treated with salvage surgery: Implications for treatment with immunotherapy. ORAL ONCOLOGY. 2026; 175DOI:10.1016/j.oraloncology.2026.107903. PMID:41722172. IF:3.900(Q1/2D).
01/04/2026
Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients
Ganoza, CA, Westenberger, A, Paul, JJ, Curado, F, Rennecke, J, Mannepalli, S, Zonic, E, Saravanakumar, D, Paknia, O, Al-Ali, R, Laabs, B, Csoti, I, Valzania, F, Vandenberghe, W, Reetz, K, Afshari, M, Hassin-Baer, S, Fonoff, ET, Gruber, D, de Rosa, A, Musacchio, T, Aguiar, PD, Negrotti, A, Tumas, V, Gomez-Esteban, JC, Gurevich, T, Pavese, N, Kulisevsky, J, Sammler, E, Klein, C, Bauer, P, Beetz, C. Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients. MOVEMENT DISORDERS. 2026; 41(4)DOI:10.1002/mds.70161. PMID:41439479. IF:7.600(Q1/1D).
01/04/2026
Geographical Differences in the Epidemiology and Treatment of Candida Prosthetic Joint Infections
Mamona-Kilu, C, Lora-Tamayo, J, McNally, M, Duran, C, Ho, RSMY, Scarborough, M, Dudareva, M, Bonnet, E, Escolà-Vergé, L, Pardo, DR, Jesuthasan, G, Senneville, E, Thill, P, Klein, S, Ronde-Oustau, C, Redó, MLS, Corvec, S, Rossi, N, Esteban, J, Lemaignen, A, Ribeiro, TC, Mazet, J, Sasso, M, Salles, MJC, Mancheño-Losa, M, Giordano, G, Frank, BJH, Hofstaetter, JG, Allende, JMB, Lortholary, O, Fourcade, C, Morata, L, Soriano, A, Dinh, A. Geographical Differences in the Epidemiology and Treatment of Candida Prosthetic Joint Infections. Open Forum Infectious Diseases. 2026; 13(4)DOI:10.1093/ofid/ofag208. PMID:41988413. IF:3.800(Q1/3D).
01/04/2026
Combining Airway Clearance Techniques and Inhaled Antibiotics in Chronic Bronchial Infection: Real-World Evidence of Exacerbation Reduction (INBREATHING Study)
Monge, A, Martinez-De las Fuentes, AM, Burgos, J, Pou, C, Lakhani, JS, Navarro, A, Castanon, RA, Garcia-Urrestarazu, EJ, Sayés, A, Alcaide, AB, Erro, M, Moreno, BR, Sánchez-Cucó, A, Santisteve, S, Benitez, ID, Moncusi-Moix, A, Gracia-Lavedan, E, Manzano, C, Morales, A, Barbé, F, Suarez-Cuartin, G, de la Rosa-Carrillo, D, de-Torres, JP, González, J. Combining Airway Clearance Techniques and Inhaled Antibiotics in Chronic Bronchial Infection: Real-World Evidence of Exacerbation Reduction (INBREATHING Study). ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(4)DOI:10.1016/j.arbres.2025.10.017. PMID:41253672. IF:9.200(Q1/1D).
01/04/2026
Influence of the level of education on cognitive function in Parkinson's disease
Santos-García, D, Fonticoba, TD, Bartolomé, CC, Alvarado, MCI, Samaniego, L, Maside, AL, Gallego, L, Barreiro, LC, Caramés, JR, Painceiras, MJF, González, JMP, Jesús, S, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, García-Soto, JD, Borrué, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Mendoza, Z, Pareés, I, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Seijo, M, Valero, C, Redondo, RA, Buongiorno, MT, Ordás, C, Menéndez-González, M, Mcafee, D, Martinez-Martin, P, Mir, P. Influence of the level of education on cognitive function in Parkinson's disease. JOURNAL OF NEURAL TRANSMISSION. 2026; 133(4)DOI:10.1007/s00702-025-03074-z. PMID:41428073. IF:4.000(Q1/2D).
01/04/2026
Declining 28-day population myocardial infarction case-fatality trends in Catalonia, Spain: an analysis of the possible contribution of emergency management network
Tizón-Marcos, H, Camps-Vilaró, A, Roman-Dégano, I, Subirana, I, Cainzos-Achirica, M, Puig, T, Mauri, J, Lidon, RM, Arbelo, E, Marrugat, J. Declining 28-day population myocardial infarction case-fatality trends in Catalonia, Spain: an analysis of the possible contribution of emergency management network. EUROPEAN JOURNAL OF PUBLIC HEALTH. 2026; 36(2)DOI:10.1093/eurpub/ckaf203. PMID:41477688. IF:3.900(Q1/2D).
01/04/2026
New GRADE Evidence-to-Decision Framework for Pairwise and Multiple Comparisons (GRADE Guidance 45)
Beltran, J, Etxeandia-Ikobaltzeta, I, Piggott, T, Akl, EA, Mustafa, RA, Hazlewood, G, Canelo-Aybar, C, Santesso, N, Brignardello-Petersen, R, Mathioudakis, AG, Carrasco-Labra, A, Nonino, F, De Beer, H, Mayer, M, Shamliyan, T, Wiercioch, W, Dietl, B, Guyatt, G, Schünemann, HJ, Alonso-Coello, P. New GRADE Evidence-to-Decision Framework for Pairwise and Multiple Comparisons (GRADE Guidance 45). ANNALS OF INTERNAL MEDICINE. 2026; 179(4)DOI:10.7326/ANNALS-25-04273. PMID:41839032. IF:15.200(Q1/1D).
01/04/2026
Conversational AI for remote monitoring in heart failure: a prospective controlled pilot study
Olivella, A, Fernández, ABM, García, EG, Torregimeno, AO, Ródenas-Alesina, E, López, RA, Pelaez, TM, Soriano-Colomé, T, Avilés, AS, Uribarri, A, Sánchez, TS, Bocanegra, CP, Baldrich, ED, Martinez-Zapata, MJ, Rubio-Valera, M, Ferreira-González, I. Conversational AI for remote monitoring in heart failure: a prospective controlled pilot study. European Heart Journal - Digital Health. 2026; 7(3)DOI:10.1093/ehjdh/ztag032. PMID:41815105. IF:(Q/D).
01/04/2026
Evaluation of the effectiveness of an intervention for the deprescription of aspirin in primary prevention of cardiovascular diseases
Girbés, AH, Moral, I, González, PB, Cuixart, L, Chaboun, N, Hernández, M, Sánchez, D, Reyes, C, Brotons, C. Evaluation of the effectiveness of an intervention for the deprescription of aspirin in primary prevention of cardiovascular diseases. Medicina De Familia-Semergen. 2026; 52(3)DOI:10.1016/j.semerg.2026.102696. PMID:41712985. IF:(Q/D).
01/04/2026
Radial macular choroidal folds: A rare finding in anti-VEGF-treated patients
Sánchez-Serra, JF, Caminal-Caramés, M, Montes, LCC, Miras, IS. Radial macular choroidal folds: A rare finding in anti-VEGF-treated patients. JOURNAL FRANCAIS D OPHTALMOLOGIE. 2026; 49(4)DOI:10.1016/j.jfo.2026.104817. PMID:41775558. IF:1.100(Q3/8D).
01/04/2026
Cutaneous Infection by Mycobacterium chelonae in the lower limbs: A study of 6 cases
Torres-Betato, F, Rusiñol, L, Gordo-Basté, M. Cutaneous Infection by Mycobacterium chelonae in the lower limbs: A study of 6 cases. MEDICINA CLINICA. 2026; 166(4)DOI:10.1016/j.medcli.2026.107363. PMID:41780141. IF:2.100(Q2/3D).
01/04/2026
Defining ascending aorta dilatation in pediatric bicuspid aortic valve: Comparison of known classical and new z-score nomograms, and anthropometric parameters indexing for its assessment
Freixa-Benavente, A, Juzga-Corrales, C, Ayerza-Casas, A, Figueras-Coll, M, Escribà-Bori, S, Plata-Izquierdo, B, Collell, R, González-Marín, MA, Siurana, JM, Sorlí-García, M, de la Torre, L, Teodoro-Marín, S, Rodriguez, M, Domínguez-García, O, Rellán, S, Manso, B, López-Abel, B, Alvarez-Pérez, R, Portillo-Márquez, M, Rezola-Arcelus, E, Centeno-Malfaz, F, Solana-Gracia, R, Rojo-Sombrero, H, Cantero-Tejedor, MT, Riaño, B, Tejero-Hernández, MA, Jiménez-Casso, M, Sabaté-Rotés, A. Defining ascending aorta dilatation in pediatric bicuspid aortic valve: Comparison of known classical and new z-score nomograms, and anthropometric parameters indexing for its assessment. Journal of Cardiology. 2026; 87(4)DOI:10.1016/j.jjcc.2025.11.001. PMID:41238104. IF:2.600(Q2/4D).
01/04/2026
Management of umbilical cord at birth in Spanish hospitals: Results of a national survey
Porcar-Farrán, D, Esmel-Vilomara, R, Becerra-Hervás, J, Salazar-Quiroz, JJ, Moliner-Calderon, E. Management of umbilical cord at birth in Spanish hospitals: Results of a national survey. ANALES DE PEDIATRIA. 2026; 104(4)DOI:10.1016/j.anpedi.2026.504142. PMID:. IF:2.100(Q2/4D).
01/04/2026
Consensus document for the transcystic approach to choledocholithiasis with ultrathin flexible choledochoscope
Garcia-Botella, A, Trujillo, JPA, de la Serna, S, Vázquez, PJG, Marchán, SJG, Llacer-Millán, E, Arnau, ABM, Martinez-Cecilia, D, Pinedo, AZ, Martinez-Isla, A. Consensus document for the transcystic approach to choledocholithiasis with ultrathin flexible choledochoscope. CIRUGIA ESPANOLA. 2026; 104(4)DOI:10.1016/j.ciresp.2025.800259. PMID:. IF:1.300(Q3/7D).
01/04/2026
New strategies to empower patients with chronic kidney disease in phosphorus control (Empower-PHOS)
Jimenez, MDA, de Polavieja, MDG, Escribano, S, Audije-Gil, J, Sánchez-Tocino, ML, Henríquez-Palop, F, Perez, GA, Yetman, D, Molina, P, Pereira, M, Bajo, MA, Lloret, MJ, Quilis, A, Fernández, C, Monteavaro, CG, Leon, LM, Botella, A, Ballart, J, Durbá, A, Furaz, K, Parra, EG, Handel, M, Yagüe, MD, Herrero, JA, Bielva, FD. New strategies to empower patients with chronic kidney disease in phosphorus control (Empower-PHOS). NEFROLOGIA. 2026; 46(4)DOI:10.1016/j.nefro.2026.501488. PMID:. IF:2.600(Q2/4D).
01/04/2026
Disease Burden and Treatment Patterns in Patients With Hidradenitis Suppurativa and Concomitant Arthritis: A Multicenter Case-Control Study
Garbayo-Salmons, P, Molina-Leyva, A, Porta-Vilaró, A, Soto-Moreno, A, Fornons-Servent, R, Gamissans, M, Garcias-Ladaria, J, Gracia-Darder, I, Martin-Ezquerra, G, Verdaguer-Faja, J, Mora-Fernández, V, Aguayo-Ortiz, RS, Vilarrasa, E, Masferrer, E, Corral-Magaña, O, Galvany, L, Rodrigo-Parés, A, Saus, E, Moreno, M, Carreras, A, Feliu-Hernàndez, C, Exposito-Serrano, V, Ribera, M, Sabat, M, Calvet, J. Disease Burden and Treatment Patterns in Patients With Hidradenitis Suppurativa and Concomitant Arthritis: A Multicenter Case-Control Study. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(4)DOI:10.1111/ijd.70125. PMID:41164894. IF:3.200(Q1/3D).
01/04/2026
Discordant Patch Test Reactions to 2-Bromo-2-Nitro-Propane-1,3-Diol (Bronopol): A Multicenter Study From REIDAC
Sánchez, TS, Giménez-Arnau, AM, Ninet, VZ, Guijarro, SC, Miquel, FJM, Salvador, JFS, Pérez, RG, González, IR, Mercader-García, P, Baldrich, ES, Carrillo, JMC, Romero, FT, De Frutos, FJO, Serna, MR, Ortega, MEG, Suárez, CP, Navarro-Triviño, F, Chicharro, P, Nieto, MAP, de la Fuente, EG, Sánchez-Gilo, A, Andreu-Barasoain, M, Rodríguez, JJP, Ninot, GMI, Guillén, PS, Elosua-González, M, Grau-Pérez, M, Descalzo, MA, Borrego, L. Discordant Patch Test Reactions to 2-Bromo-2-Nitro-Propane-1,3-Diol (Bronopol): A Multicenter Study From REIDAC. CONTACT DERMATITIS. 2026; 94(4)DOI:10.1111/cod.70082. PMID:41456936. IF:4.600(Q1/1D).
01/04/2026
Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis The BE RADIANT Randomized Clinical Trial With Open-Label Extension
Augustin, M, Feldman, SR, Warren, RB, Armstrong, A, Vender, R, López-Ferrer, A, Dawe, WH, Lambert, J, Szilagyi, B, Hoepken, B, Warham, R, Gottlieb, AB. Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis The BE RADIANT Randomized Clinical Trial With Open-Label Extension. JAMA Dermatology. 2026; 162(4)DOI:10.1001/jamadermatol.2025.6055. PMID:41706476. IF:11.000(Q1/1D).
01/04/2026
Risk factors for close or involved margins in cutaneous squamous cell carcinoma of the scalp
Verdaguer-Faja, J, Ferrándiz-Pulido, C, Podlipnik, S, Guerra-Amor, A, Abril-Pérez, C, Estrada, RB, Masferrer, E, Lopez-Castillo, D, Deza, G, Leal, L, Marti-Marti, I, Ruiz-Salas, V, Yébenes, M, Martin, LM, Baliu, C, Castany, A, Boada, A, Toll, A, Jaka, A. Risk factors for close or involved margins in cutaneous squamous cell carcinoma of the scalp. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2026; 40(4)DOI:10.1111/jdv.20872. PMID:40709565. IF:8.000(Q1/1D).
01/04/2026
From 'nice to have' to 'must have': Integrating ultrasound into routine care of hidradenitis suppurativa
Vilarrasa, E. From 'nice to have' to 'must have': Integrating ultrasound into routine care of hidradenitis suppurativa. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2026; 40(4)DOI:10.1111/jdv.70312. PMID:41879066. IF:8.000(Q1/1D).
01/04/2026
Promoting Well-Being and Workforce Inclusion Through Healthy Leisure: Evidence from a Community-Based Youth Intervention
Brugueras, S, Continente, X, Daban, F, March, S, García, I, Vázquez, N, Lopez, MJ. Promoting Well-Being and Workforce Inclusion Through Healthy Leisure: Evidence from a Community-Based Youth Intervention. Journal of Prevention. 2026; 47(2)DOI:10.1007/s10935-025-00889-0. PMID:41359211. IF:1.500(Q3/7D).
01/04/2026
Older adults and major cardiovascular events requiring emergency department consultation during the 1st wave of the COVID-19 pandemic: results from the EDEN-4 Study
Salmerón, PP, Jacob, J, Miró, O, Burillo-Putze, G, García-Lamberechts, EJ, Pérez, FJM, Aguiló, S, Fernández, C, Alquézar-Arbé, A, Olagüenaga, AM, Miguez, FJD, Sousa, M, Asensio, PR, Díaz, BP, Pizarro, TP, Gómez, MAD, Viola, NP, Hernández-Castells, L, Soler, AC, Sardina, VD, Serrano, JAS, Ezponda, P, Lorenzo, AM, Liarte, JVO, Fernández, RH, Aranda, AR, del Castillo, JG. Older adults and major cardiovascular events requiring emergency department consultation during the 1st wave of the COVID-19 pandemic: results from the EDEN-4 Study. EMERGENCIAS. 2026; 38(2)DOI:10.55633/s3me/027.2026. PMID:41880167. IF:6.300(Q1/1D).
01/04/2026
First-in-class SAM-competitive G9a inhibitor FLAV-27 as adisease-modifying therapy for Alzheimer disease
Bellver-Sanchis, A, Valle-Garcia, D, Barbaraci, C, Romero-Becerra, F, Singh, RK, Jarne-Ferrer, J, Vasilopoulou, F, Irisarri, A, Martínez-Fernández, C, Fafián-Labora, JA, Arufe, MC, Wüst, C, Castellanos, A, Soto, D, Casals, N, Fadó, R, Pocock, JM, Navarro, G, Val, C, Brea, J, Loza, MI, Lleó, A, Fortea, J, Alcolea, D, Perez-Bosque, A, Miró, L, Pérez, B, Rashid, S, Ali, M, Saqib, M, li Carbó, M, Guerrero, A, Vázquez, S, Choudhary, BS, Dai, SD, Escolano, C, Franco, R, Pallàs, M, Griñán-Ferré, C. First-in-class SAM-competitive G9a inhibitor FLAV-27 as adisease-modifying therapy for Alzheimer disease. MOLECULAR THERAPY. 2026; 34(4)DOI:10.1016/j.ymthe.2025.12.038. PMID:41445192. IF:12.000(Q1/1D).
01/04/2026
Metabolic brain networks in dementia with Lewy bodies: from prodromal to manifest disease stages
Perovnik, M, Simoncic, U, Jamsek, J, Kramberger, MG, Brumberg, J, Meyer, PT, Perani, D, Caminiti, SP, Brendel, M, Stockbauer, AC, Camacho, V, Alcolea, D, Vandenberghe, R, Van Laere, K, Ko, JH, Lee, CS, Pardini, M, Lombardo, L, Padovani, A, Pilotto, A, Ochoa-Figueroa, MA, Davidsson, A, Cháfer-Pericás, C, Alvarez-Sánchez, L, Garibotto, V, Lemstra, AW, Ferreira, D, Morbelli, SD, Tang, CC, Eidelberg, D, Trost, M. Metabolic brain networks in dementia with Lewy bodies: from prodromal to manifest disease stages. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2026; 97(4)DOI:10.1136/jnnp-2025-336935. PMID:41344886. IF:7.500(Q1/1D).
01/04/2026
Tuberculosis outbreak in a pre-primary and primary school in Barcelona, Spain
Prieto-García, R, Millet, JP, Broto, C, Lara, E, Espiau, M, Soriano-Arandes, A, de Souza-Galvao, ML, Jiménez-Fuentes, MA, Domingo, C, Vallverdú, RMV, Saludes, V, Bordoy, AE, Hesketh-Best, PJ, Yagüe, DP, Martró, E, Mestre, LG, Torres, ES, Alguacil, HM, Espinilla, ML, Cardona, PJ, Simón, P, Rius, C. Tuberculosis outbreak in a pre-primary and primary school in Barcelona, Spain. Frontiers in Public Health. 2026; 14DOI:10.3389/fpubh.2026.1789425. PMID:41994511. IF:3.400(Q1/2D).
01/04/2026
Clinical protocol for the use of biologic therapy in COPD
Rubio, MC, Soler-Cataluña, JJ, Campos, JLL, Navarrete, BA, González, FJC, Garin, N, Bernabéu-Morai, R, Rivasj, PC, Triguerosk, GE, Figueira-Gonçalves, JM, Gomila, AF, Mayoral, RG, Monge, GLA, Oto, MM, Martin, EM, de Miguel-Diez, J, Riesco, JA, Garcia, CR, Pérez, SS, Ecenarro, PS, Delgado, MS, Miravitlles, M. Clinical protocol for the use of biologic therapy in COPD. RESPIRATORY MEDICINE. 2026; 254DOI:10.1016/j.rmed.2026.108718. PMID:41722824. IF:3.100(Q2/4D).
01/04/2026
Reliable designs of breast sharing based on the internal mammary perforator flap for breast reconstruction
Rodriguez, C, Angrigiani, C, Pons, G, Van Landuyt, K, Masia, J. Reliable designs of breast sharing based on the internal mammary perforator flap for breast reconstruction. Journal of Plastic Reconstructive and Aesthetic Surgery. 2026; 115DOI:10.1016/j.bjps.2026.02.054. PMID:41861757. IF:2.400(Q1/3D).
01/04/2026
Propeller Modification of Tapia's Flap
Angrigiani, C, Masia, J, Peñaranda, A, Rancati, A, Felice, F, Dip, F, Rancati, A. Propeller Modification of Tapia's Flap. Aesthetic Surgery Journal. 2026; 46(4)DOI:10.1093/asj/sjaf216. PMID:41129682. IF:3.900(Q1/1D).
01/04/2026
Update and summary of the EAU/ESPU paediatric guidelines on urinary tract infection in children
Gnech, M, Bujons, A, Radmayr, C, Hoen, L, Bogaert, G, Burgu, B, Rawashdeh, YF, Silay, MS, O'Kelly, F, Quaedackers, J, Pakkasjärvi, N, van Uitert, A, Skott, M, Kennedy, U, Yuan, YH, Zachou, A, Castagnetti, M. Update and summary of the EAU/ESPU paediatric guidelines on urinary tract infection in children. Journal of Pediatric Urology. 2026; 22(2)DOI:10.1016/j.jpurol.2025.06.016. PMID:40615247. IF:1.900(Q2/5D).
01/04/2026
Barriers to pregnancy and parenthood during urology residency across Europe
Afferi, L, Margue, G, Toribio-Vázquez, C, Melsert, BM, Baekelandt, L, Goujon, A, Ozalevli, M, Checcucci, E, Lazos, AG, Siech, C, Vásquez, JL, Mertens, LS, Liatsikos, E, Somani, BK, Pradere, B, Whitburn, J, Wyler, S, Breda, A, Phé, V, Weissman, JS, Rangel, E. Barriers to pregnancy and parenthood during urology residency across Europe. Bjui Compass. 2026; 7(4)DOI:10.1002/bco2.70181. PMID:42022230. IF:(Q/D).
01/04/2026
Acetazolamide effects on natriuresis and diuresis in acute heart failure treated with furosemide and SGLT2i (SANDI)
González, JG, Magaña, JG, Llàcer, P, Pal, AF, Trullàs, JC, Zegrí-Reiriz, I, Díez-Villanueva, P, Fernandez, AE, Manzano, LP, Fernández, ABM, Pérez, PC, López-Azor, JC, Martínez, R, D'Amato, M, Pascual, CF, Ruiz-Ruiz, E, Pisón, EP, Anter, MB, Marcos, MC. Acetazolamide effects on natriuresis and diuresis in acute heart failure treated with furosemide and SGLT2i (SANDI). ESC Heart Failure. 2026; 13(2)DOI:10.1093/eschf/xvag096. PMID:41920937. IF:3.700(Q1/3D).
01/04/2026
Prognostic Impact of Echocardiographic and Right Heart Catheterization-Derived Optimal Profiles in LVAD Patients
Bofarull, JG, Gallone, G, Thirupathirajan, V, Benedicto, AM, Javier, I, Synowiec, E, Guichard, J, Vella, MM, Saez, DG, Shanmuganathan, M, Fiorelli, F, Dar, O, Morley-Smith, A, Gil, FR. Prognostic Impact of Echocardiographic and Right Heart Catheterization-Derived Optimal Profiles in LVAD Patients. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Hypercoagulability in Prader-Willi Syndrome: A case-control study exploring coagulation profiles and thrombotic risk
Vallès-Cardona, G, Caixàs, A, Berges, I, Perea, G, Vilalta, N, Corripio, R. Hypercoagulability in Prader-Willi Syndrome: A case-control study exploring coagulation profiles and thrombotic risk. GENETICS IN MEDICINE. 2026; 28(4)DOI:10.1016/j.gim.2026.102536. PMID:41685566. IF:6.200(Q1/1D).
01/04/2026
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks
Gorog, DA, ten Berg, JM, Campo, G, Geisler, T, Gigante, B, Grove, EL, Halvorsen, S, Huber, K, Jeong, YH, Lip, GYH, Navarese, EP, Rubboli, A, Matula, JMS, Storey, RF, Valgimigli, M, Vandenbriele, C, Vilahur, G, Ahrens, I, Ferreiro, JL. Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. European Heart Journal-Acute Cardiovascular Care. 2026; 15(4)DOI:10.1093/ehjacc/zuag021. PMID:41914626. IF:4.600(Q1/2D).
01/04/2026
Relationship between body mass index and endogenous fibrinolytic status in 600 patients with ST-elevation myocardial infarction
Leader, JH, Vilahur, G, Ajjan, RA, Kanji, R, Gue, YX, Farag, M, Gorog, DA. Relationship between body mass index and endogenous fibrinolytic status in 600 patients with ST-elevation myocardial infarction. CARDIOVASCULAR RESEARCH. 2026; 122(6)DOI:10.1093/cvr/cvag047. PMID:41757699. IF:13.300(Q1/1D).
01/04/2026
Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST study
Marques-Pamies, M, Ricou, L, Gil, J, Sampedro-Núñez, M, Biagetti, B, Giménez-Palop, O, Hernández, M, Martínez, S, Carrato, C, Villar-Taibo, R, Araujo-Castro, M, Blanco, C, Simón-Muela, I, Simó-Servat, A, Xifra, G, Vázquez, F, Pavón, I, Rosado, JA, García-Centeno, R, Zavala, R, Hanzu, FA, Mora, M, Aulinas, A, Vilarrasa, N, Torres, A, Librizzi, S, Calatayud, M, Novoa, PD, Alvarez-Escola, C, Picó, A, Salinas, I, Fajardo-Montañana, C, Cámara, R, Bernabéu, I, Jordà, M, Webb, SM, Marazuela, M, Valassi, E, Puig-Domingo, M. Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST study. Journal Of The Endocrine Society. 2026; 10(4)DOI:10.1210/jendso/bvag030. PMID:41798894. IF:(Q/D).
01/04/2026
Efficacy and safety of osilodrostat in patients with ectopic Cushings syndrome. a real-world study in Spain
Araujo-Castro, M, Garcia-Centeno, R, Fernández, LG, Soto-Moreno, A, Camara, R, García, MDO, Echarri, AI, Gracia, P, Pascual-Corrales, E, Biagetti, B, Cardona, A, Molero, IG, Simo-Servat, A, Guerrero-Perez, F, Villar-Taibo, R, Bernabéu, I, Fajardo-Montañana, C, Novo-Rodríguez, C, Tenorio-Jimenéz, C, Calatayud, M, Rodríguez, MDM, Cordido, F, Castro, A, Valero, LM, Paja, M, Goi, J, Aulinas, A, Abellán, P, Iglesias, P, Hanzu, FA. Efficacy and safety of osilodrostat in patients with ectopic Cushings syndrome. a real-world study in Spain. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2026; 49(4)DOI:10.1007/s40618-025-02769-0. PMID:41335191. IF:3.500(Q2/4D).
01/04/2026
Question: A striking central venous pressure waveform leading to the diagnosis
Ferrer-Menéndez, M, Taroncher-Domingo, C, Duran-Cambra, A. Question: A striking central venous pressure waveform leading to the diagnosis. European Heart Journal-Acute Cardiovascular Care. 2026; 15(4)DOI:10.1093/ehjacc/zuaf149. PMID:41883263. IF:4.600(Q1/2D).
01/04/2026
Answer: A striking central venous pressure waveform leading to the diagnosis
Ferrer-Menéndez, M, Taroncher-Domingo, C, Duran-Cambra, A. Answer: A striking central venous pressure waveform leading to the diagnosis. European Heart Journal-Acute Cardiovascular Care. 2026; 15(4)DOI:10.1093/ehjacc/zuaf150. PMID:41922903. IF:4.600(Q1/2D).
01/04/2026
Heart Transplantation in Cardiac Amyloidosis. Management and Outcomes. Data from the Spanish Heart Transplant Registry
Ballesteros, MA, Barge-Caballero, G, Herrador, L, Gomez-Bueno, M, Caravaca, P, de Antonio-Ferrer, M, Vilella, RL, Rivas, S, Manrique-Antón, R, Palacios-Castelló, C, Cobo-Belaustegui, M, Crespin-Crespin, M, de la Fuente-galán, L, de Sanmamed-Girón, MF, Ortiz-Bautista, C, Diaz-Molina, B, Blasco-Peiró, T, Barge-Caballero, E, Crespo-LeiroServicio, MG. Heart Transplantation in Cardiac Amyloidosis. Management and Outcomes. Data from the Spanish Heart Transplant Registry. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Timing of Lung Cancer Diagnosis After Heart Transplantation: Impact of Symptom Status on Stage, Treatment, and Outcomes
Cosio, MG, Severo, A, Gonzalez-Vilchez, F, Lopez-Vilella, R, Bueno, MG, Couto-Mallon, D, Blazquez, Z, Caravaca, P, Alarcos, H, Molina, BD, Romero, EG, Perez, SM, Marquez, MS, Bravo, IG, Tobar, J, Peiro, MB, Muñiz, J, Delgado, J. Timing of Lung Cancer Diagnosis After Heart Transplantation: Impact of Symptom Status on Stage, Treatment, and Outcomes. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Profiling Late Right Ventricular Failure Beyond 6 Months Post-LVAD Implantation: Phenotyping, Predictors, and Prognosis
Bofarull, JG, Gallone, G, Thirupathirajan, V, Benedicto, AM, Javier, I, Wypych-Zych, A, Jean-Baptiste, G, Vella, MM, Saez, DG, Shanmuganathan, M, Fiorelli, F, Dar, O, Morley-Smith, A, Gil, FR. Profiling Late Right Ventricular Failure Beyond 6 Months Post-LVAD Implantation: Phenotyping, Predictors, and Prognosis. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Hemodynamic Optimization and Hemocompatibility Outcomes in LVAD Recipients
Bofarull, JG, Gallone, G, Thirupathirajan, V, Benedicto, AM, Ibero, J, Topciu, T, Guichard, J, Vella, MM, Saez, DG, Shanmuganathan, M, Fiorelli, F, Dar, O, Morley-Smith, A, Gil, FR. Hemodynamic Optimization and Hemocompatibility Outcomes in LVAD Recipients. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Defining Noninvasive Criteria for Indicating Drug Therapy in Metabolic Dysfunction-associated Steatotic Liver Disease in Clinical Practice
Olveira, A, Crespo, J, Ibañez-Samaniego, L, Gallego-Durán, R, Calleja, JL, Aller, R, Soria, A, Gómez-Camarero, J, Martín-Mateos, R, Benlloch, S, Pericàs, JM, Morillas, RM, Bernal-Monterde, V, Diago, M, Turnes, J, Poca, M, Lo Iacono, O, Maya-Miles, D, Escudero, D, Andrade, RJ, Rosales, JM, Jorquera, F, Fernández-Rodriguez, C, Hernández-Guerra, M, Romero-Gómez, M, Ampuero, J. Defining Noninvasive Criteria for Indicating Drug Therapy in Metabolic Dysfunction-associated Steatotic Liver Disease in Clinical Practice. Clinical Gastroenterology and Hepatology. 2026; 24(4)DOI:10.1016/j.cgh.2025.08.023. PMID:40907848. IF:12.000(Q1/1D).
01/04/2026
Analytical and Clinical Validation of Action PharmaKitDx: A Comprehensive NGS Panel for the Identification of Pharmacogenetic Variants in Diverse Populations
Ramudo-Cela, L, Izquierdo-García, M, Dolores-Sequedo, M, Cubells-Perez, V, Bernal, S, Riera, P, Lasa, A, Torres-Juan, L, Asensio, VJ, Martínez-López, I, de Hevia, AO, Morín, M, Moreno-Pelayo, MA, Carmona-Antoñanzas, G, Pelayo, JP. Analytical and Clinical Validation of Action PharmaKitDx: A Comprehensive NGS Panel for the Identification of Pharmacogenetic Variants in Diverse Populations. Pharmaceuticals. 2026; 19(4)DOI:10.3390/ph19040568. PMID:42075824. IF:4.800(Q1/2D).
01/04/2026
Diagnostic yield of chromosomal microarray and virtual targeted gene panel analysis in adults with focal epilepsy: implications for sequential genetic testing strategy
Panadés-de Oliveira, L, Galeote, MS, Duran, EP, Vilella, L, Garcia, ACD, Principe, A, Metje, AP, Marti, IC, Pérez-Jurado, LA, Zucca, R, Boronat, S, Rocamora, R. Diagnostic yield of chromosomal microarray and virtual targeted gene panel analysis in adults with focal epilepsy: implications for sequential genetic testing strategy. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY. 2026; 137DOI:10.1016/j.seizure.2026.02.021. PMID:41785580. IF:2.800(Q2/5D).
01/04/2026
Risk of delayed atrioventricular block in patients without procedural conduction disturbances during transcatheter aortic valve replacement
Fischer, Q, Nombela-Franco, L, Muntané-Carol, G, Veiga, G, Regueiro, A, Nazif, T, Serra, V, Asmarats, L, Ribeiro, HB, Latib, A, Poulin, A, Cheema, AN, Jiménez-Quevedo, P, Gomez-Hospital, JA, Ongay, AG, Ruberti, A, Arzamendi, D, Brener, M, Calabuig, A, Scotti, A, Gelain, MAS, Labinaz, M, Cepas-Guillén, P, Côté, M, del Portillo, JH, Philippon, F, Rodés-Cabau, J. Risk of delayed atrioventricular block in patients without procedural conduction disturbances during transcatheter aortic valve replacement. HEART RHYTHM. 2026; 23(4)DOI:10.1016/j.hrthm.2025.04.017. PMID:40239910. IF:5.700(Q1/2D).
01/04/2026
Rationale and design of the Pre-MYO project: a precision-medicine platform for myocarditis diagnosis and management
Pascual-Figal, DA, García-Serna, AM, Esteban-Gil, A, Fuster, JJ, Martín, P, Sánchez-Cabo, F, Uribarri, A, Iniesta-Manjavacas, AM, Larrañaga-Moreira, JM, Lopez-Fernandez, S, Pastor-Pueyo, P, Diez-Lopez, C, Flórez, JMV, Bueno, H, Sanmartin-Fernandez, M, Fernández-Martínez, J, Alvarez, BA, Martinez, AT, Domínguez, F. Rationale and design of the Pre-MYO project: a precision-medicine platform for myocarditis diagnosis and management. ESC Heart Failure. 2026; 13(2)DOI:10.1093/eschf/xvag022. PMID:41711201. IF:3.700(Q1/3D).